Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹419 Cr₹1,066 Cr₹921 Cr₹1,218 Cr₹1,091 Cr

What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS is ₹419 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹419 Cr
Mar2023₹1,066 Cr
Mar2022₹921 Cr
Mar2021₹1,218 Cr
Mar2020₹1,091 Cr

How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2024 ₹419 Cr
-60.66
Mar2023 ₹1,066 Cr
15.71
Mar2022 ₹921 Cr
-24.36
Mar2021 ₹1,218 Cr
11.66
Mar2020 ₹1,091 Cr -

Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,842.8 Cr 4.8% 5.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.9% 1.8% 14% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 5.7% 9.6% 58.6% Stock Analytics
CIPLA ₹121,122.0 Cr -0.8% 1.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,487.0 Cr 0.8% 1.2% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,680.0 Cr 2.9% 6.5% 4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.8%

5.2%

40%

SENSEX

3.6%

9.5%

13.3%


You may also like the below Video Courses